MaxLinear Director Awarded 15,741 Restricted Stock Units (RSUs)
MAXLINEAR, INC
Subscribe to track MXL
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
MaxLinear Director Awarded 15,741 Restricted Stock Units (RSUs)
Company: MAXLINEAR, INC (MXL) Form: 4/A | Filed: 2025-10-10 Significance: Low
Insider: Tewksbury Ted L III Title: Director | Relationship: Director
Transaction: • Type: Grant (Award) • Shares: 15,741 Restricted Stock Units • Price: $0.00 • Value: $0 • Owned After: 15,741
Key Insight: A Director received a grant of RSUs as part of their compensation. This is an amended filing (4/A) to correct the number of units previously reported. The transaction is not an open-market purchase and has a future vesting date.
This is PUBLIC SEC data for educational purposes. Not investment advice.
Comprehensive Analysis
SEC Filing Analysis: MAXLINEAR, INC (MXL)
Executive Summary
- Trading Significance: Low
- Key Takeaway: A Director, Ted L. Tewksbury III, was granted 15,741 Restricted Stock Units (RSUs) as part of a standard compensation package. This Form 4/A amends a previous filing from May 22, 2025, to correct the number of RSUs reported. The transaction holds no immediate market value and is not an indicator of insider sentiment via open-market activity.
- Market Impact: Neutral. As this is a routine, non-market equity grant to a director and a correction of a prior filing, it is not expected to have a material impact on the stock price or trading volume.
Company Information
| Field | Value |
|---|---|
| Company | MAXLINEAR, INC |
| Ticker Symbol | MXL |
| CIK | 0001288469 |
| Industry | Semiconductors & Related Devices |
Insider Information
| Field | Value |
|---|---|
| Name | Tewksbury Ted L III |
| CIK | 0001375681 |
| Title/Position | Director |
| Relationship | Director |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 4/A (Amendment) |
| Transaction Date | 2025-05-20 |
| Transaction Code | A (Grant, award, or other acquisition) |
| Security Type | Restricted Stock Units |
| Shares Involved | 15,741 |
| Price Per Share | $0.00 |
| Total Value | $0 |
| Shares Owned After | 15,741 |
| Ownership Type | Direct |
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: This transaction is a grant of equity compensation, not an open-market purchase or sale. Such grants are standard practice for board members and do not reflect an insider's immediate outlook on the company's stock performance. The fact that it is a correction to a previous filing further diminishes its significance as new information.
Volume & Sentiment
- Expected Volume Impact: Negligible. The filing is informational and unlikely to drive trading activity.
- Sentiment Indicator: Neutral. The grant aligns the director's interests with shareholders over the long term but does not provide a short-term bullish or bearish signal.
Investment Insights
Positive Market Indicators
- Equity compensation helps align the interests of the board with those of the shareholders.
Risk Factors
- No immediate risk factors are apparent from this filing. It is a routine corporate governance event.
Key Takeaways
- Correction Filing: This is an amendment (Form 4/A) to correct the number of RSUs reported in a filing on May 22, 2025. This suggests an administrative correction rather than a new event.
- Standard Compensation: The award of RSUs to a director is a common form of non-cash compensation intended to retain and incentivize board members.
- Future Vesting: The RSUs will vest on the earlier of May 1, 2026, or the day before the next annual stockholders' meeting, contingent on the director's continued service. This is a long-term incentive.
Contextual Analysis
Timing Significance
The filing date of October 10, 2025, is nearly five months after the original transaction and filing period. The delay is due to the nature of this being a corrective amendment.
Transaction Context
Footnote 2 explicitly states: "This amendment is being filed to correct the number of RSUs reported in the Form 4 filed May 22, 2025." Footnote 1 clarifies that each RSU represents a right to receive one share of common stock. Footnote 3 outlines the vesting schedule, which is typical for such awards.
Company Context
Without additional current news, this filing should be viewed in the context of MaxLinear's standard director compensation policies. It does not signal any new strategic shifts or operational developments.
Risk Assessment
Risk Level: Low
Risk Factors
- This filing itself presents no material risks to investors.
Market Considerations
- Investors should interpret this filing as a routine administrative and governance update, not as a trading signal.
IMPORTANT DISCLAIMER: This analysis is for informational purposes only and is not intended as investment advice. The information presented is based on publicly available SEC filings and should not be construed as a recommendation to buy, sell, or hold any securities. Past performance does not guarantee future results. All investments carry risk, including the potential loss of principal. Please consult with a qualified financial advisor before making any investment decisions.
Analysis generated on 2025-10-10 | Data source: SEC EDGAR
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.